Unlike in other countries, Medicare has no way to negotiate what it pays for prescription drugs.
— Libby Nelson (@libbyanelson) June 10, 2021
What could go wrong?
Well, hypothetically, you could end up with a $56,000 treatment with little evidence of effectiveness, and no way to bargain it down. https://t.co/ShLM6dPWpY pic.twitter.com/F3HU4UC7nJ